Willett GD, Kurman RJ, Reid R, et al. Correlation of the histologic appearance of intraepithelial neoplasia of the cervix with human papillomavirus types: emphasis on low grade lesions including so-called ﬂat condyloma. Int J Gynecol Pathol 1989;8:18–25.
48.
Ismail SM, Colclough AB, Dinnen JS, et al. Reporting cervical intra-epithelial neoplasia (CIN): intra-and interpathologist variation and factors associated with disagreement. Histopathology 1990;16: 371–376.
49.
Sherman ME, Schiffman MH, Erozan YS, et al. The Bethesda System: a proposal for reporting abnormal cervical smears based on the reproducibility of cytopathologic diagnoses. Arch Pathol Lab Med 1992;116:1155–1158.
50.
Ries L, Eisner MP, Kosary CL, et al. SEER Cancer Statistics Review, 1975–2002. Bethesda, MD: National Cancer Institute, 2004.
51.
Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2006. CA Cancer J Clin 2006;56:106–130.
52.
U.S. Department of Health and Human Services. Healthy people 2010. Washington, DC: U.S. Government Printing Office, 2000.
53.
McCrory DC, Matchar DB, Bastian L, et al. Evaluation of cervical cytology. Evidence Report/Technology Assessment No. 5. (Prepared by Duke University under Contract No. 290-97-0014.) AHCPR Publication No. 99-E010. Rockville, MD: Agency for Health Care Policy and Research. February 1999.
54.
Fahey MT, Irwig L, Macaskill P. Meta-analysis of Pap test accuracy. Am J Epidemiol 1995;141:680–689.
55.
Mitchell MF, Schottenfeld D, Tortolero-Luna G, et al. Colposcopy for the diagnosis of squamous intraepithelial lesions: a meta-analysis. Obstet Gynecol 1998;91:626–631.
56.
Nanda K, McCrory DC, Myers ER, et al. Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review. Ann Intern Med 2000;132:810– 819.
57.
Sawaya GF, Grimes DA. New technologies in cervical cytology screening: a word of caution. Obstet Gynecol 1999;94:307–310.
58.
Wright TC Jr, Cox JT, Massad LS, et al. ASCCP-Sponsored Consensus Conference. 2001 Consensus Guidelines for the management of women with cervical cytological abnormalities. JAMA 2002;287:2120–2129.
59.
Bolick DR, Hellman DJ. Laboratory implementation and efficacy assessment of the ThinPrep cervical cancer screening system. Acta Cytol 1998;42:209–213.
60.
McQuarrie HG, Ogden J, Costa M. Understanding the financial impact of covering new screening technologies: the case of automated Pap smears. J Reprod Med 2000;45:898–906.
61.